KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 90 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,263 | +15.7% | 131,147 | +8.1% | 0.01% | +75.0% |
| Q2 2023 | $1,092 | +930.2% | 121,353 | +671.3% | 0.01% | +700.0% |
| Q4 2022 | $106 | -100.0% | 15,734 | -5.0% | 0.00% | -66.7% |
| Q3 2022 | $240,000 | +46.3% | 16,557 | -0.8% | 0.00% | +50.0% |
| Q2 2022 | $164,000 | +3.8% | 16,691 | +39.6% | 0.00% | +100.0% |
| Q4 2021 | $158,000 | -49.7% | 11,956 | -33.6% | 0.00% | 0.0% |
| Q3 2021 | $314,000 | -43.2% | 17,998 | -22.1% | 0.00% | -66.7% |
| Q2 2021 | $553,000 | -4.0% | 23,090 | +3.0% | 0.00% | 0.0% |
| Q1 2021 | $576,000 | +453.8% | 22,412 | +309.3% | 0.00% | +200.0% |
| Q4 2020 | $104,000 | – | 5,476 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|